Elos Medtech – effects of final acquisition analysis relating to Onyx Medical
Elos Medtech acquired the North American company Onyx Medical LLC in April 2015. The comparison of the final acquisition analysis with the preliminary acquisition analysis has required a revaluation of primarily intangible assets, such as customer relationships and goodwill, resulting in a total increase of about SEK 40 M. The effect of this is an increase of approximately SEK 0.8 M in the amortisation cost for previously reported quarters in 2015. Furthermore, a nonrecurring cost of approximately SEK 3 M has arisen for changes in inventory, which has impacted earnings for 2015, implying a